Announcing our newest cancer test. Screen cancer early with Onco-D-clare. Learn more

News & events

Watch this space for news and events from our RGCC team. Join us on this journey where knowledge meets experience, and discover the pulse of RGCC’s impact on the future of healthcare.

Podcasts

Immerse yourself in the latest talks and podcasts, where leading experts delve into the forefront of personalized cancer care.

RGCC's events

Stay informed about our events, conferences, podcasts, and videos! Don't miss out on an opportunity to connect, learn, and engage with our team.

  • Oct 17th-19th 2024
    RGCC North America Gathering

    Our RGCC providers are invited to come to the RGCC North America Gathering this Fall! Please click here to register: https://rgccna.swoogo.com/2024fallgathering/

    June 3rd, 2024
    Wellness Warriors: Breast Cancer Conqueror

    Dr. Lauren and Dr. V (Veronique Desaulniers - The Breast Cancer Conqueror) discuss how integrating RGCC testing with any treatment protocol, adds precision and personalization, removing the uncertainty of the one-size-fits all models, saving time, money, and ultimately improving outcomes.

    Listen hereVisit Page
    May 16th, 2024
    BeatCancer.org

    Dr. Lauren met with the BeatCancer.org coaching community, a compassionate and caring group of patient advocates to discuss their excitement and desire to share RGCC and the power of personalized testing with their coaching clients.

    Visit Page
  • May 4th-5th, 2024
    Clinical Protocols:
    A Systems Biology Approach

    Dr. Lauren and Dustin Baker were excited to introduce RGCC to this dynamic community rooted in a forward-focused mission to redefine modern medicine. We are excited to represent RGCC at the 2024 Longevity Fest in Vegas this December!

    Visit Page
    Coming in August!
    Podcast with Beljanski Foundation

    Dr. Lauren was honored to meet with Sylvie Beljanski and Victor Dwyer of the Beljanski Foundation for an informative Q&A to introduce RGCC's personalized testing to their community.

    Watch this space for a link to the interview.
    February 24th-25th, 2024
    2024 Best Answers For Cancer Conference

    Dr. Lauren Cohen and Mindy Anderson from RGCC North America join the Best Answers for Cancer Conference.

    This conference brings together leading experts and researchers in integrative oncology to share cutting-edge insights and strategies for cancer prevention and treatment. Dr. Cohen and Mindy share insights about RGCC's advanced approaches to personalized cancer care and how they are revolutionizing the field.

    Visit Page
  • February 22nd-24th, 2024
    Annie Appleseed Project: Complementary & Alternative Cancer Therapies Conference

    Dr. Lauren Cohen from RGCC North America presented at the Annie Appleseed Project’s Complementary & Alternative Cancer Therapies Conference.

    This is a unique opportunity to explore a diverse range of alternative therapies and integrative approaches to cancer treatment. Dr. Lauren Cohen and Mindy Anderson share their insights on RGCC's innovative contributions to personalized cancer care and how they are shaping the future of oncology. 

    Visit Page
    January 16th-22nd, 2024
    Breast Cancer Breakthroughs Summit: Personalized Cancer Care: The Power of Precision Testing

    Discover insights from Dr. Lauren Cohen's compelling talk at the Breast Cancer Breakthroughs Summit. In her session, Dr. Cohen illuminates the shortcomings of the traditional one-size-fits-all cancer treatment model. 

    Learn how personalized testing empowers patients by offering tailored insights into their unique cancer biology, enabling them to take control of their treatment journey. Gain valuable knowledge on the transformative potential of personalized testing in oncology and understand why it is crucial for more targeted and effective treatment strategies.

    Visit PageVisit Page

Videos

Explore our curated collection of videos, providing an in-depth look at our innovative solutions and groundbreaking research.

Bita Badakhshan - RGCC Gathering 2023 Interview

Watch an interview with Dr. Bita Badakhshan, a seasoned practitioner in primary family medicine with over 12 years of experience in integrative oncology and functional medicine.

In this video, Dr. Bita shares her experience with RGCC’s revolutionary liquid biopsy testing. She highlights the unparalleled precision and detail offered by RGCC's advanced methodologies over other laboratories.

Dr. Bita emphasizes the unmatched sensitivity of RGCC's testing, which delves deep into analyzing stem cells, cancer cells, and a comprehensive array of markers crucial for personalized cancer care.

Since 2012, Dr. Beta has trusted RGCC for blood testing on patients, particularly focusing on circulating tumor cell analysis and using RGCC’s OncoCount and OncoTrace tests along with the Onconomics Plus assessments.

Through RGCC's innovative tests and therapies, Dr. Bita has been able to make informed decisions sparing many patients from unnecessary chemotherapy and radiation post-tumor removal surgeries.

Read more about our therapies on our website: https://rgcc-international.com/rgcc-therapies/

RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou who believes that the key to effectively treating cancer lies in personalized medicine using the information in a patient’s genes.

Individualized treatment for cancer is the focus behind RGCC’s testing protocols and advanced therapy options. Our slate of tests analyzes the state of a person’s cancer by looking at the cellular and genetic makeup of each patient. Our test results give you information that acts as a blueprint for what treatment protocols are likely to show the most efficacy for your specific biology.

Learn more about RGCC at
https://rgcc-international.com/

Follow us on social media to find out the latest news and updates from our experts.

Facebook: https://www.facebook.com/profile.php?id=61554630098937

Instagram: https://www.instagram.com/rgcc_north_america/

LinkedIn: https://www.linkedin.com/company/r-g-c-c-international-gmbh/

Dr. John Soo - RGCC Gathering 2023 Interview

Watch an interview with Dr. John Soo from Singapore, a seasoned practitioner of integrative medicine with a focus on functional wellness for over 13 years.

Dr. Soo commends RGCC for providing not just investigations but comprehensive treatment modalities and options for cancer care. With his background in integrative medicine, Dr. Soo emphasizes the importance of viewing cancer as a multi-dimensional problem.

Dr. Soo has used RGCC's meticulous testing protocols over the last 4-5 years with great success. He attests to the precision and efficacy of selecting supplements tailored to each patient's unique needs.

By leveraging RGCC's insights, Dr. Soo navigates treatment selections for his patients with confidence, optimizing both time and resources to ensure the best outcomes for them.

RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou who believes that the key to effectively treating cancer lies in personalized medicine using the information in a patient’s genes.

Individualized treatment for cancer is the focus behind RGCC’s testing protocols and advanced therapy options. Our slate of tests analyzes the state of a person’s cancer by looking at the cellular and genetic makeup of each patient. Our test results give you information that acts as a blueprint for what treatment protocols are likely to show the most efficacy for your specific biology.

Learn more about RGCC at
https://rgcc-international.com/

Follow us on social media to find out the latest news and updates from our experts.

Facebook: https://www.facebook.com/profile.php?id=61554630098937

Instagram: https://www.instagram.com/rgcc_north_america/

LinkedIn: https://www.linkedin.com/company/r-g-c-c-international-gmbh/

Follow Us
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
EOF GMP COSMETICS – SUPPLEMENTS
View Certificate
Accreditations
IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
99D2283882
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate
Accreditation Certificate of Foreign Cell Processor - Japanese Government
View Certificate
EOF GMP COSMETICS – SUPPLEMENTS
View Certificate
Call
Text
Email
Map